Clinical Effects of New Approach on Patients With Non-alcoholic Steatohepatitis

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

175

Participants

Timeline

Start Date

December 17, 2023

Primary Completion Date

June 17, 2024

Study Completion Date

June 27, 2024

Conditions

Non-alcoholic Steatohepatitis

Interventions

DRUG

Rosuvastatin 20mg

to evaluate and compare the protective outcomes of using Rosuvastatin, Vitamin E, and N-acetyl cysteine in Egyptian patients with NASH.

Trial Locations (1)

Tanta university hospital, Tanta

All Listed Sponsors

lead

Beni-Suef University

OTHER

NCT06105060 - Clinical Effects of New Approach on Patients With Non-alcoholic Steatohepatitis | Biotech Hunter | Biotech Hunter